IM Cannabis Prices $1.31M Direct Offering at $2.00, Citing Financial Hardship
IMCC has more than doubled off its 52-week low of $1.55 on elevated volume (12× avg).
Summary
IM Cannabis priced a registered direct offering of 655,000 shares at $2.00, raising $1.31 million before expenses. The deal is deeply dilutive relative to the $7.74 market price and follows a pattern of small, high-cost financings. The company disclosed that one or more purchasers may be related parties and that it is relying on financial hardship exemptions under MI 61-101, which requires a board determination that the company is in serious financial difficulty. This confirms the liquidity strain already evident from recent convertible note raises and the Q2 going concern warning. The offering is expected to close September 24, 2026.
At the time of this announcement, IMCC was trading at $7.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6M. The 52-week trading range was $1.55 to $77.10. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.